SCHEMBL12286208

SCHEMBL12286208

CC(=O)C(C)(C)CN1CCN(C(=O)c2ccc(-c3cc4nccc(Oc5ccc(NC(=O)NC6CC6)cc5F)c4s3)nc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 12/20 0.49
▸ KDR P35968 12/20 0.49
▸ MST1R Q04912 12/20 0.47
▸ AXL P30530 2/20 0.46
▸ FLT3 P36888 2/20 0.46
▸ NTRK1 P04629 1/20 0.46
▸ KIT P10721 1/20 0.46
▸ NTRK2 Q16620 1/20 0.46
▸ PLK4 O00444 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ LCK P06239 1/20 0.44
▸ FYN P06241 1/20 0.44
▸ LYN P07948 1/20 0.44
▸ HCK P08631 1/20 0.44
▸ PDGFRB P09619 1/20 0.44
▸ BCR P11274 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ ABL2 P42684 1/20 0.44
▸ FRK P42685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12252321 0.95 MET (0.49) METKDRMST1RAXLFLT3
SCHEMBL12252135 0.94 MET (0.49) METKDRMST1RAXLFLT3
SCHEMBL12288521 0.91 MET (0.51) METKDRMST1RAXLFLT3
SCHEMBL2535813 0.89 MET (0.51) METKDRMST1RAXLFLT3
SCHEMBL2538077 0.89 MET (0.53) METKDRMST1RAXLFLT3
Acetic Acid SCHEMBL2535932 0.89 MET (0.49) METKDRMST1RAXLFLT3
SCHEMBL12252327 0.88 MET (0.52) METKDRMST1RAXLFLT3
SCHEMBL2533080 0.88 MET (0.54) METKDRMST1RAXLFLT3
SCHEMBL12252324 0.88 MET (0.50) METKDRMST1RAXLFLT3
SCHEMBL12252257 0.88 MET (0.49) METKDRMST1RAXLFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011127567-A1 INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY METHYLGENE INC. (CA) 2011-10-20 — — WO disclosed
Send feedback